Cancer & Disease Research
Burning Rock Biotech highlights breast cancer study using its genomic profiling test
Precision oncology firm Burning Rock Biotech on Thursday announced that its genomic profiling test, OncoScreen Plus, was used in a phase III multiregional breast cancer clinical trial, alongside Foundation Medicine's FoundationOneCDx. Read More
Quantification of long COVID fatigue shows impact is worse than some cancers
Fatigue is the most impactful symptom in the lives of people suffering from long COVID, with patients reporting worse scores than individuals with some cancers. Read More
Heart failure reversed in unprecedented case
Three people with heart failure caused by the build-up of sticky, toxic proteins are now symptom-free after their condition spontaneously reversed -- an unprecedented medical event. The study, supported by the Royal Free Charity and published Wednesday as a letter in The New England Journal of Medicine, found that three men, initially diagnosed with transthyretin cardiac amyloidosis, had virtually recovered. Read More
FDA updates recommendations to modernize design, conduct of clinical trials
The U.S. Food and Drug Administration (FDA) on Tuesday released a draft guidance document with updated recommendations for good clinical practices aimed at modernizing the design and conduct of clinical trials. Read More
Targeted erdafitinib therapy clinical trials achieve benefits across multiple cancer types
Three clinical trials demonstrated positive results from targeted erdafitinib therapy for patients with multiple tumor types harboring FGFR alterations. The research, funded by pharmaceutical company Janssen Research & Development, was presented at the 2023 American Society of Clinical Oncology’s annual meeting, held from June 2 to June 6 in Chicago. Read More
BioCentriq, Kytopen expand partnership on cell therapy manufacturing technology
BioCentriq, a contract development and manufacturing organization specializing in cell therapy, and Kytopen, a Massachusetts Institute of Technology-based startup, on Tuesday announced that they are expanding their partnership. Read More
Advanced lung cancer treatment can stop after two years: Study
A large, retrospective cohort study found that indefinite immunotherapy did not improve survival in patients with advanced lung cancer. The research, published Sunday in JAMA Oncology, was also presented at the 2023 American Society of Clinical Oncology annual meeting in Chicago. Read More
Antibody treatment may shrink bile duct tumors
An antibody treatment in a study helped shrink tumors in some patients with bile duct cancer. The research, published Friday in the Lancet Oncology and presented at the American Society of Clinical Oncology’s 2023 annual meeting, focused on patients whose tumors produce a high amount of the HER2 protein, causing cells to multiply too quickly. Read More
Thermo Fisher Scientific introduces high-resolution, high-throughput mass spectrometer
Thermo Fisher Scientific on Monday introduced its Orbitrap Astral mass spectrometer, which combines high resolution, high throughput, and high speed with deep proteome coverage. Read More
Long COVID symptoms reported by 17% of unvaccinated people
Swiss researchers have found that about 17% of unvaccinated people report experiencing COVID-19-related health problems up to two years after SARS-CoV-2 infection. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter